Dr. Reddy's to Release Q1 FY14 Results on July 30, 2013

  Dr. Reddy's to Release Q1 FY14 Results on July 30, 2013

         Earnings call slated for July 30, 6.30 PM IST / 9.00 AM EDT*

Business Wire

HYDERABAD, India -- July 19, 2013

Dr. Reddy's Laboratories (NYSE: RDY) will announce results for the First
Quarter ended June 30, 2013 on Tuesday, July 30, 2013 after the Board Meeting.
The results will be available on the Company’s website www.drreddys.com.

Summary of Events

Event                  Date and Time (IST)      Medium
Release of financial   July 30th, after the     Email, Media, Company
results                  Board Meeting              website, Business Wire
Earnings Call          July 30th, 6.30 PM IST   Hosted by the Company
                         / 9:00 AM EDT              (Details below)
                         July 30th, 6.30 PM IST     URL available on Company’s
Webcast of Earnings    / 9.00 AM EDT through    website,
Call                     August 4th, 2013
                                                    www.drreddys.com
Transcripts of the     Will be available on     URL available on Company’s
Earnings call            the Company’s website      website, www.drreddys.com
                                               

Earnings Call

Following the release, the management of the Company will host an earnings
call to discuss the Company’s financial performance.


Conference Dial-In Numbers
Primary Number:              +91 22 6629 0356
Secondary Number:            +91 22 3065 0136
The numbers listed above are universally accessible from all networks and all
countries.
                               6000 1221
                               Available in - Ahmedabad, Bangalore,
                               Bhubaneswar, Chandigarh, Chennai, Coimbatore,
                               Delhi, Goa, Guntur, Gurgaon, Hyderabad, Indore,
                               Jamshedpur, Kanpur, Kochi/Cochin, Kolhapur,
                               Kolkata, Nagpur, Noida, Patna, Pune, Raipur,
Local Access Number:         Rajkot, Surat, Trivandrum, Vadodara, Vijayawada
                               Accessible from all major carriers except
                               BSNL/MTNL.
                               3940 3977
                               Available in Ahmedabad, Bangalore, Chandigarh,
                               Chennai, Kochi/Cochin, Gurgaon (NCR),
                               Hyderabad, Kolkata, Lucknow, Pune
                               Accessible from all carriers.
                               USA: 1 866 746 2133
International Toll Free        UK: 0 808 101 1573
Number:
                               Singapore: 800 101 2045
                            Hong Kong: 800 964 448
                               

No password/pin number is necessary to dial in to any of the other calls. As
participation in the call is limited, early registration is encouraged. The
operator will provide instructions on asking questions before and during the
call.

Audio Webcast

The audio webcast of the earnings call will be available to all interested
parties at www.drreddys.com. Please visit the web site at least fifteen
minutes ahead of the scheduled start time to register and to download and
install any necessary audio software. Participants in the webcast can listen
to the proceedings, but will not be able to ask questions. The replay will be
available 2 hours after the earnings call, through August 4th, 2013. For play
back dial in phone No: 022 3065 1212 and ID: 375#.

Transcript

The transcript of the earnings call will also be available on the Company's
website.

About Dr. Reddy’s

Dr. Reddy’s Laboratories Ltd. (NYSE: RDY) is an integrated global
pharmaceutical company, committed to providing affordable and innovative
medicines for healthier lives. Through its three businesses – Pharmaceutical
Services and Active Ingredients, Global Generics and Proprietary Products –
Dr. Reddy’s offers a portfolio of products and services including APIs, custom
pharmaceutical services, generics, biosimilars and differentiated
formulations. Major therapeutic focus is on gastro-intestinal, cardiovascular,
diabetology, oncology, pain management and anti-infective. Major markets
include India, USA, Russia-CIS and Europe apart from other select geographies
within Emerging Markets.

For more information, log on to: www.drreddys.com

*EDT- Eastern Daylight Saving Time

Contact:

Investor Relations:
Dr. Reddy's Laboratories
Kedar Upadhye, +91 40 66834297
kedaru@drreddys.com
or
Saunak Savla, +91 40 49002135
saunaks@drreddys.com
or
Milan Kalawadia (USA), +1 9082034931
mkalawadia@drreddys.com
 
Press spacebar to pause and continue. Press esc to stop.